Skip to content

Mobile Medically Supervised Patient Management in Rheumatoid Arthritis

Mobile Medically Supervised Patient Management in Rheumatoid Arthritis Patients Using DocuMed.rh and RheumaLive App

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02565225
Acronym
MiDEAR
Enrollment
60
Registered
2015-10-01
Start date
2014-11-30
Completion date
2016-07-31
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

The purpose of this study is to evaluate the use, usability and feasibility of an Application (App) for patients with rheumatoid arthritis with diary functionalities, in patient-physician interaction.

Interventions

BEHAVIORALRheumaLive App use

Sponsors

Heinrich-Heine University, Duesseldorf
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \>= 18 years, owner of App capable device, RA, informed consent

Exclusion criteria

* non German speaking, no App capable device available

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of use of the RheumaLive Application in patients with rheumatoid arthritis.baseline and change over up to nine monthsEvaluation of use by counting and by a patient paper-based questionnaire

Secondary

MeasureTime frameDescription
Comparison paper-based vs electronic PROM in the App - Differences of the scoresbaseline and change after 3 monthsRADAI - Rheumatoid Arthritis Disease Activity Index and FFbH (Hannover Functional Ability Questionnaire ) / calculated HAQ (Health Assesment Questionnaire)
Evaluation of feasibility of the RheumaLive Application in patients with rheumatoid arthritis.at 3 months from start and change over 6 more monthsEvaluation of feasibility by a patient and a physician paper-based questionnaire
Evaluation of usability of the RheumaLive Application in patients with rheumatoid arthritis.at 3 months from start and change over 6 more monthsEvaluation of usability by a patient paper-based questionnaire

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026